Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Superinvestors holding MCRB, Q2 2026
No superinvestor reported holding MCRB in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of MCRB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−18.1%)